1 Ridge CA, Pua BB, Madoff DC. Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol. 2014; 31:3-8.
2 Liu K, Wang P, Zhu X, et al. Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer. Cancer Manag Res. 2018; 10:2259-2268.
3 Takada S, Namiki M, Takahara S, et al. Serum HGF levels in acute renal rejection after living related renal transplantation. Transpl Int. 1996; 9:151-4.
4 Meehan B, Appu S, St Croix B, et al. Age-related properties of the tumour vasculature in renal cell carcinoma. BJU Int. 2011; 107:416-24.
5 Al-Janabi O, Wach S, Nolte E, et al. Piwi-like 1 and 4 gene transcript levels are associated with clinicopathological parameters in renal cell carcinomas. Biochim Biophys Acta. 2014; 1842:686-90.
6 Yusim I, Mermershtain W, Neulander E, et al. Influence of age on the prognosis of patients with renal cell carcinoma (RCC). Onkologie. 2002; 25:548-50.
7 Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 2004; 10:7252-9.
8 Taccoen X, Valeri A, Descotes JL, et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol. 2007; 51:980-7.
9 Aziz A, May M, Zigeuner R, et al. Do young patients with renal cell carcinoma feature a distinct outcome after surgery? A comparative analysis of patient age based on the multinational CORONA database. J Urol. 2014; 191:310-5.
10 Kang HW, Seo SP, Kim WT, et al. Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study. J Korean Med Sci. 2016; 31:1976-1982.
11 Kim JH, Park YH, Kim YJ, et al. Is there a difference in clinicopathological outcomes of renal tumor between young and old patients? A multicenter matched-pair analysis. Scand J Urol. 2016; 50:387-91.
12 Komai Y, Fujii Y, Iimura Y, et al. Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology. 2011; 77:842-7.
13 Jung EJ, Lee HJ, Kwak C, et al. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Urology. 2009; 73:137-41.
14 Malouf GG, Camparo P, Oudard S, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol. 2010; 21:1834-8.
15 Mitchell TJ, Turajlic S, Rowan A, et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal. Cell. 2018; 173:611-623.
16 Malouf GG, Camparo P, Molinié V, et al. Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors. J Urol. 2011; 185:24-9.
17 Abbott GW. KCNE4 and KCNE5 K(+) channel regulation and cardiac arrhythmogenesis. Gene. 2016; 593:249-60.
18 Arabzadeh A, Troy TC, Turksen K. Role of the Cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo. Mol Cell Biol. 2006;26:5876–5887.
19 Yang M, Li Y, Shen X, Ruan Y, Lu Y, Jin X, Song P, Guo Y, Zhang X, Qu H, et al. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer. J Exp Clin Cancer Res. 2017;36:157.
20 Guo Y, Lin D, Zhang M, et al. CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells. Int J Oncol. 2016;48:2435–2444.
21 Gao F, Li M, Xiang R, Zhou X, Zhu L, Zhai Y. Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis. Oncol Lett. 2019;17(5):4621-4625
22 Lin Z, Witschas K, Garcia T, et al. A critical GxxxA motif in the gamma6 calcium channel subunit mediates its inhibitory effect on Cav3.1 calcium current. J Physiol. 2008; 586:5349-66.
23 Lee JS, Kim JH, Bae JS, et al. Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet. 2010; 11:138.
24 Patel NH, Attwood KM, Hanzly M, et al. Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes. J Urol. 2012; 194:640-6.
25 Kroeger N, Klatte T, Birkhäuser FD, et al. Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer. 2012; 118:1795-802.
26 Golabek T, Bukowczan J, Szopinski T, et al. Obesity and renal cancer incidence and mortality--a systematic review of prospective cohort studies. Ann Agric Environ Med. 2016; 23.37-43.
27 Park J, Morley TS, Kim M, et al. Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014; 10: 455-465
28 Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7.245-57.
29 Colt JS, Schwartz K, Graubard BI, et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology. 2011; 22.797-804.